# Drug Hunter

> Drug Hunter is a Boston-based knowledge platform for the scientists who turn molecules into medicines. Founded in 2018 by former Genentech chemist Dennis X. Hu, it distills scientific literature, patents, and early disclosures into searchable, expert-curated insights - molecule search, patent search, courses, flash talks, and a mobile app. More than 200 R&D organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, and the NIH, rely on it. In September 2025 the company raised a seed round led by Teamworthy Ventures.

- **Founded:** 2018
- **Headquarters:** Boston, Massachusetts, United States
- **Founders:** Dennis X. Hu (Founder & CEO)
- **Team size:** ~150 (per Apollo data; company also references a distributed team across Boston, Nashville, and New York)
- **Products:** Molecule Search, Patent Search, Educational Course, Flash Talks, Mobile App (iOS & Android)
- **Notable:** Trusted by 200+ pharmaceutical and biotech R&D organizations worldwide, Adopted by industry leaders including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, and the NIH, Raised a seed round led by Teamworthy Ventures in September 2025

## Products & services

- **Molecule Search** — A searchable database of drug structures and molecular insights distilled from scientific literature, patents, and early disclosures by industry scientists.
- **Patent Search** — Tools to search and analyze patent disclosures relevant to drug discovery programs and competitive intelligence.
- **Educational Course** — Structured courses on drug discovery topics such as structure-based design, modalities, and the druggable interactome.
- **Flash Talks** — Short-form curated scientific talks and content highlighting key developments in medicinal chemistry and drug discovery.
- **Mobile App (iOS & Android)** — A mobile application that surfaces new drug disclosures and curated insights to scientists as they happen.

## Achievements

- Trusted by 200+ pharmaceutical and biotech R&D organizations worldwide
- Adopted by industry leaders including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, and the NIH
- Raised a seed round led by Teamworthy Ventures in September 2025
- Grew from a scientist's side project in 2018 into a widely used industry knowledge platform
- Launched a mobile app surfacing drug disclosures to scientists in real time

## Latest updates

- **2025-09** — Announced a seed investment led by Teamworthy Ventures to expand scientific coverage, enrich chemical structure databases, improve search and analytics, and build out its mobile application.
- **2026-01** — Published 'Molecules of the Month - January 2026' and course content on the druggable interactome across its channels.

## Links

- Website: https://drughunter.com
- LinkedIn: https://www.linkedin.com/company/drughunter
- Twitter/X: https://twitter.com/drughunter_com
- YouTube: https://www.youtube.com/@drughunter
- Instagram: https://www.instagram.com/drughunterofficial/
- Facebook: https://www.facebook.com/drughunterofficial/

---

Profile page: https://yespress.io/drug-hunter
Published by YesPress — https://yespress.io
Last updated: 2026-08-06